← Back to Clinical Trials
Recruiting NCT06694584

NCT06694584 Study: Tea(m)Time - Strengthening the Team Resilience of Hospital Staff Through the Tea(m)Time Intervention

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06694584
Status Recruiting
Phase —
Sponsor Catholic University of Applied Sciences Mainz
Condition Resilience, Psychological
Study Type INTERVENTIONAL
Enrollment 150 participants
Start Date 2024-03-04
Primary Completion 2026-11-20

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Tea(m)Time

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 150 participants in total. It began in 2024-03-04 with a primary completion date of 2026-11-20.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Employees in hospitals are exposed to various stressors and can be at risk of psychological stress. To counteract this, resilience programs are increasingly being offered. Most interventions focus on individual resilience. In this study, the focus is on the resilience of teams. For this reason, this research paper will focus on the Tea(m)Time intervention. Tea(m)Time is a health promotion intervention that combines the risk assessment of mental stress with a focus on team resilience. In order to generate knowledge about the Tea(m)Time intervention, this study aims to identify factors that promote and inhibit its implementation and mediate its effectiveness. The aim is to gain insights into the promotion of resilience in teams. The aim is to conduct the survey of the participants in the intervention group and the control group at three different points in time.

Eligibility Criteria

Inclusion criteria: * be at least 18 years old * have sufficient knowledge of German * are not on sick leave at time t0 * work in one of the planned clinics Exclusion criteria: * be younger than 18 years old * do not have sufficient knowledge of German * are on sick leave at time t0 * do not work in one of the planned clinics

Contact & Investigator

Central Contact

Ivonne Ledtermann, MSc

✉ ivonne.ledtermann@kh-mz.de

📞 +49 6131 289 44-185

Principal Investigator

Nadine Ungar, Dr.

PRINCIPAL INVESTIGATOR

Professorship for Psychology in Healthcare

Frequently Asked Questions

Who can join the NCT06694584 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Resilience, Psychological. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06694584 currently recruiting?

Yes, NCT06694584 is actively recruiting participants. Contact the research team at ivonne.ledtermann@kh-mz.de for enrollment information.

Where is the NCT06694584 trial being conducted?

This trial is being conducted at Bad Kreuznach, Germany, Bad Kreuznach, Germany, Meisenheim, Germany.

Who is sponsoring the NCT06694584 clinical trial?

NCT06694584 is sponsored by Catholic University of Applied Sciences Mainz. The principal investigator is Nadine Ungar, Dr. at Professorship for Psychology in Healthcare. The trial plans to enroll 150 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology